OncoSpherix News & Events
Rob Scott
Robert Scott, MD, has joined the Board of Directors of OncoSpherix. Dr. Scott has held leadership positions in global Pharma for over thirty years. At Pfizer, he developed Lipitor and Norvasc. He also invented and developed the first commercially available Polypill,...
Virtual Precision in Drug Discovery & Preclinical Summit
October, 2020: OncoSpherix’s CEO, Dr. Margaret K. Offermann, served as Keynote Speaker and Session Chairperson in the Virtual Precision in Drug Discovery & Preclinical Summit. Her presentation was titled “Development of First-in-Class Small Molecule Dual HIF-1 and...
Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma
OncoSpherix was awarded a $399,774 phase 1 SBIR from the NCI in for a project entitled “Arylsulfonamides for the Treatment of Primary and Metastatic Uveal Melanoma”.
Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors”
US Patent entitled “Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors” was awarded to Georgia State University Research Foundation and to Emory University. It is included in the portfolio that OncoSpherix licensed from the...
OncoSpherix selected as a Cade Prize Fibonacci Finalist for Inventors and Entrepreneurs
OncoSpherix selected as a Cade Prize Fibonacci Finalist for Inventors and Entrepreneurs: Since 2010, the Cade Prize has celebrated innovation by identifying, recognizing, and celebrating Florida-based inventors and entrepreneurs at the pre-seed and seed stages. The...
Semi-finalist in the AIM-HI Women’s Venture Competition
Dr Margaret Offermann, CEO of OncoSpherix, is among the 8 semi-finalist in the AIM-HI Women’s Venture Competition: The 8 semifinalists were selected from a pool of 47 candidates from 6 countries. “The Women’s Venture Competition is one of the first venture-backed...
Agile Falcon 5th Drug Discovery Strategic Summit
May, 2020: OncoSpherix’s CEO, Dr. Margaret K. Offermann, served as Keynote Speaker and Session Chairperson in the Agile Falcon 5th Drug Discovery Strategic Summit. Her talk was titled “Discovery and Development of Small Molecule Inhibitors of Hypoxia Inducible Factors...